Edition:
United Kingdom

MYOS RENS Technology Inc (MYOS.OQ)

MYOS.OQ on NASDAQ Stock Exchange Capital Market

1.30USD
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
$1.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,402
52-wk High
$2.50
52-wk Low
$1.05

Chart for

About

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle... (more)
No analyst recommendations are available for .

Overall

Beta: 0.27
Market Cap(Mil.): $7.89
Shares Outstanding(Mil.): 5.84
Dividend: --
Yield (%): --

Financials

  MYOS.OQ Industry Sector
P/E (TTM): -- 22.52 40.76
EPS (TTM): -0.71 -- --
ROI: -67.54 12.26 62.30
ROE: -68.27 15.63 73.91

BRIEF-Myos Rens Technology Reports Qtrly Loss Per Share $0.19

* MYOS RENS TECHNOLOGY REPORTS FIRST QUARTER FINANCIAL RESULTS

09 May 2018

BRIEF-Joseph Mannello Reports 9.3 Pct Stake In Myos Rens Technology Inc

* JOSEPH MANNELLO REPORTS 9.3 PERCENT STAKE IN MYOS RENS TECHNOLOGY INC AS OF APRIL 27, 2018 - SEC FILING Source text: (https://bit.ly/2FTnvnk) Further company coverage:

07 May 2018

BRIEF-David Matlin Reports 8.29 Pct Passive Stake In MYOS RENS Technology As Of April 25, 2018

* DAVID J. MATLIN REPORTS 8.29 PERCENT PASSIVE STAKE IN MYOS RENS TECHNOLOGY AS OF APRIL 25, 2018 - SEC FILING Source text : (https://bit.ly/2rgSl4d) Further company coverage:

02 May 2018

BRIEF-Myos Rens Says Qtrly Net Loss Rose 44 Pct To $1.1 MLN

* MYOS RENS TECHNOLOGY REPORTS FOURTH QUARTER AND FISCAL 2017 FINANCIAL RESULTS

27 Mar 2018

BRIEF-Myos Rens Technology Announces Research Agreement With Rutgers University

* MYOS RENS TECHNOLOGY, INC. ANNOUNCES RESEARCH AGREEMENT WITH RUTGERS UNIVERSITY FOCUSED ON DISCOVERY OF COMPOUNDS AND PRODUCTS FOR IMPROVING MUSCLE HEALTH AND PERFORMANCE Source text for Eikon: Further company coverage:

27 Mar 2018

Competitors

Earnings vs. Estimates